Breaking News

KBI Biopharma and Selexis Appoint Abdelaziz Toumi as Chief Business Officer

Toumi will lead Global Business Development for KBI and Selexis, spearheading the long-term client growth strategy and the building of strategic relationships.

Author Image

By: Charlie Sternberg

Associate Editor

KBI Biopharma Inc. and Selexis SA have appointed Abdelaziz Toumi, Ph.D. as the companies’ chief business officer.   Toumi brings more than two decades of global expertise in biotech, pharmaceutical, and CDMO industries, demonstrating visionary and strategic leadership.   In his role, Toumi will lead Global Business Development for KBI and Selexis, spearheading the long-term client growth strategy and the building of key strategic relationships. In addition, he will lead the Program Managemen...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters